RANK/RANKL pathway in cancer: Biological activity beyond bone?

Affiliations

¹ Department of Medical Oncology, Campus Bio-Medico University of Rome, Rome, Italy; INSERM, Research Unit U1033, University of Lyon-1, Faculty of Medicine Laennec, rue Guillaume Paradin, 69372 Lyon cedex 08, France.
² INSERM, Research Unit U1033, University of Lyon-1, Faculty of Medicine Laennec, rue Guillaume Paradin, 69372 Lyon cedex 08, France.
³ Department of Medical Oncology, Campus Bio-Medico University of Rome, Rome, Italy.

Francesco Pantano et al. J Bone Oncol. 2012.

. 2012 Nov 29;1(3):67-8.

doi: 10.1016/j.jbo.2012.11.001. eCollection 2012 Dec.

¹ Department of Medical Oncology, Campus Bio-Medico University of Rome, Rome, Italy; INSERM, Research Unit U1033, University of Lyon-1, Faculty of Medicine Laennec, rue Guillaume Paradin, 69372 Lyon cedex 08, France.
² INSERM, Research Unit U1033, University of Lyon-1, Faculty of Medicine Laennec, rue Guillaume Paradin, 69372 Lyon cedex 08, France.
³ Department of Medical Oncology, Campus Bio-Medico University of Rome, Rome, Italy.

No abstract available

References

1. Anderson D.M., Maraskovsky E., Billingsley W.L., Dougall W.C., Tometsko M.E., Roux E.R. A homologue of the TNF receptor and its ligand enhance T-cell growth and dendritic-cell function. Nature. 1997;390:175–179. - PubMed
1. Kong Y.Y., Yoshida H., Sarosi I., Tan H.L., Timms E., Capparelli C. OPGL is a key regulator of osteoclastogenesis, lymphocyte development and lymph-node organogenesis. Nature. 1999;397:315–323. - PubMed
1. Santini D., Galluzzo S., Zoccoli A., Pantano F., Fratto M.E., Vincenzi B. New molecular targets in bone metastases. Cancer Treatment Reviews. 2010;36(Suppl. 3):S6–S10. - PubMed
1. Gonzalez-Suarez E., Jacob A.P., Jones J., Miller R., Roudier-Meyer M.P., Erwert R. RANK ligand mediates progestin-induced mammary epithelial proliferation and carcinogenesis. Nature. 2010;468:103–107. - PubMed
1. Schramek D., Leibbrandt A., Sigl V., Kenner L., Pospisilik J.A., Lee H.J. Osteoclast differentiation factor RANKL controls development of progestin-driven mammary cancer. Nature. 2010;468:98–102. - PMC - PubMed